K
Kevin Lee
Researcher at Jewish Hospital
Publications - 10
Citations - 135
Kevin Lee is an academic researcher from Jewish Hospital. The author has contributed to research in topics: Thrombophilia & Cholesterol. The author has an hindex of 6, co-authored 10 publications receiving 112 citations.
Papers
More filters
Journal ArticleDOI
Associations between Serum 25-hydroxyvitamin D and Lipids, Lipoprotein Cholesterols, and Homocysteine.
Charles J. Glueck,Vybhav Jetty,Matan Rothschild,Gregory Duhon,Parth Shah,Marloe Prince,Kevin Lee,Michael Goldenberg,Ashwin Kumar,Naila Goldenberg,Ping Wang +10 more
TL;DR: Fasting serum vitamin D was positively correlated with age, HDLC, and White race, and was inversely correlated with BMI, total and LDL cholesterol, triglyceride, and fasting serum homocysteine, and a significant independent positive determinant of HDLC.
Journal ArticleDOI
Safety of 50,000-100,000 units of vitamin D3/week in vitamin D-deficient, hypercholesterolemic patients with reversible statin intolerance
Vybhav Jetty,Charles J. Glueck,Ping Wang,Parth Shah,Marloe Prince,Kevin Lee,Michael Goldenberg,Ashwin Kumar +7 more
TL;DR: Vitamin D3 therapy (50,000-100,000 IU/week) was safe and effective when given for 12 months to reverse statin intolerance in patients with vitamin D deficiency, and there was no significant change in serum calcium or eGFR.
Journal ArticleDOI
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy
Charles J. Glueck,Parth Shah,Naila Goldenberg,Marloe Prince,Kevin Lee,Vybhav Jetty,Ashwin Kumar,Michael Goldenberg,Ping Wang +8 more
TL;DR: If 30 % of patients with high LDLC and HeFH-CVD are eligible for PCSK9 inhibitors, then specialty pharmaceutical pricing models will collide with tens of millions of HeFH and CVD patients.
Journal ArticleDOI
Thrombophilia in 153 Patients With Premature Cardiovascular Disease ≤Age 45
Alexander Milgrom,Kevin Lee,Matan Rothschild,Frini Makadia,Greg Duhon,Sarah Min,Ping Wang,Charles J. Glueck +7 more
TL;DR: In 153 patients with premature CVD ≤ age 45, thrombophilia was pervasive (high factor VIII, homocysteine, ACLA IgM, low free protein S, high Lp(a), and lupus anticoagulant), evidencing throm botic contribution to premature CVC.
Journal ArticleDOI
Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy
Michael Ian Jarman,Kevin Lee,Ariel Kanevsky,Sarah Min,Ilana Schlam,Chris Mahida,Ali Huda,Alexander Milgrom,Naila Goldenberg,Charles J. Glueck,Ping Wang +10 more
TL;DR: Idiopathic ON, often caused by thrombophilia-hypofibrinolysis, is worsened by TT, and its progression may be slowed or stopped by discontinuation of TT and, thereafter, anticoagulation.